v3.25.2
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Impairment Effects on Earnings Per Share [Line Items]    
Cash and Cash Equivalents $ 6,832,725 $ 1,848,295
Cash [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 130,288 109,659
Unrealized Gain (Loss)
Fair Value
Cash and Cash Equivalents 130,288 109,659
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 6,702,437 1,738,636
Unrealized Gain (Loss)
Fair Value 6,702,437 1,738,636
Cash and Cash Equivalents 6,702,437 1,738,636
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 6,832,725 1,848,295
Unrealized Gain (Loss)
Fair Value 6,702,437 1,738,636
Cash and Cash Equivalents $ 6,832,725 $ 1,848,295